Research article · 3 Jan 2024
Research articlePublished 17 May 2022
Analysis of Drug Formulary Exclusions from the Patient's Perspective
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: Pharmacy benefit management companies (PBMs) often determine medication reimbursement with formularies, which were initially intended to ensure use of the least-costly still effective medication. Today, formularies are designed to maximise concessions (ie, rebates and fees) from PBMs through the biopharmaceutical industry. Exclusions may no longer benefit patients by controlling costs, but rather serve to enhance the ability to drive the amount gained through rebate contracting. In this brief report, we evaluate excluded drugs on the only national formulary that is publicly available in the US from the perspective of whether or not the exclusions benefit patients. Methods: We analysed exclusions of the 2022 national formulary of the second-largest PBM in the US that is publicly available. We categorised substitutions as equivalent (same active agent used) vs. therapeutic (different active agent). We evaluated each exclusion by potential clinical or economic outcomes from a patient perspective. Results: Close to half (46%) of the 563 exclusions had questionable clinical or financial benefits to patients, requiring prescribers to choose treatments that may have adverse financial or medical outcomes for their patients. Conclusions: Because patient co-pays and deductibles are based on retail prices, some formulary exclusions force patients to pay substantially more for a preferred drug than an excluded drug or use a medication with questionable medical benefit for their condition. Further research is needed to understand how many patients are affected by such exclusions.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Case report · 29 Jan 2021
A Heavily Treated HIV-1 Infected Patient with Multiclass Drug Resistance: A Case Report and Review of Management Challenges in Settings with a Limited Formulary
Other · 13 Jul 2016
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Research article · 2017
National Survey of Drug Information Centers Practices: Hospital Formulary System at Ministry of Health Hospital in Saudi Arabia
Conference abstract · 19 Dec 2014
Evaluation of bacterial resistance pattern among thalassemia patients for updating hospital drug formulary
More from this journal
The newest in Health Science Journal.
Editorial · 31 Dec 2025
Energy-Boosting Nutrition: Fueling the Body for Optimal Performance and Vitality
Editorial · 31 Dec 2025
Digestive Balance: Maintaining a Healthy Gut for Optimal Digestion and Well-being
Editorial · 31 Dec 2025
Prebiotics: Exploring the Role of Dietary Components in Supporting Gut Health and Overall Wellness
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHealth Science Journal
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Robert Popovian”
- BylineArticles whose byline prints “Anne M. Sydor”
- BylineArticles whose byline prints “Peter Pitts”

